3
Announcements
Trials
Browse
Landscape
Status
Completed
9
Unknown
6
Recruiting
5
Enrolling by invitation
2
Active not recruiting
2
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Neuroendocrine Tumors
46
Pituitary Neoplasms
19
Neoplasms
14
Thyroid Neoplasms
13
Pheochromocytoma
13
Thyroid Carcinoma, Anaplastic
12
Thyroid Cancer, Papillary
12
Neoplasm Metastasis
12
Adrenocortical Carcinoma
11
Paraganglioma
9
Insulinoma
9
Carcinoid Tumor
9
Adrenal Gland Neoplasms
9
Somatostatinoma
8
Glucagonoma
8
Colorectal Neoplasms
8
Carcinoma, Renal Cell
8
Carcinoma, Islet Cell
8
Pancreatic Neoplasms
7
Gastrinoma
7
Carcinoma, Neuroendocrine
7
Breast Neoplasms
7
Melanoma
6
Head and Neck Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Adenoma, Islet Cell
6
Small Cell Lung Carcinoma
5
Multiple Endocrine Neoplasia Type 1
5
Lung Neoplasms
5
Gastro-enteropancreatic neuroendocrine tumor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Hyperaldosteronism
×
Endocrine
×
Clear all
NCT05456997
2023-10-16
LYDIA
Barts & The London NHS Trust
Terminated
1 enrolled